v3.26.1
Equity - Stockholders Equity (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Increase (Decrease) in Stockholders' Equity            
Balance at beginning of period   $ 4,295     $ 4,295  
Net income attributable to Ingredion $ 114   $ 196   256 $ 393
Less: Net income attributable to non-controlling interests (2)   (2)   (4) (4)
Balance at end of period 4,524       4,524  
Increase (Decrease) in Temporary Equity            
Share-based payments subject to redemption, beginning balance 41 64 42 $ 60 64 60
Share-based compensation, net of issuance 8 (23) 9 (18) (15) (9)
Share-based payments subject to redemption, ending balance 49 41 51 42 49 51
Redeemable non-controlling interests, beginning balance 0 7 8 7 7 7
Purchases of non-controlling interests   (7)     (7)  
Other comprehensive income     (1) 1    
Redeemable non-controlling interests, ending balance $ 0 $ 0 $ 7 $ 8 0 7
Dividends declared (in dollars per share) $ 0.82 $ 0.82 $ 0.80 $ 0.80    
Common Stock            
Increase (Decrease) in Stockholders' Equity            
Balance at beginning of period $ 1 $ 1 $ 1 $ 1 1 1
Balance at end of period 1 1 1 1 1 1
Additional Paid-In Capital            
Increase (Decrease) in Stockholders' Equity            
Balance at beginning of period 1,162 1,155 1,158 1,152 1,155 1,152
Share-based compensation, net of issuance 1 7 2 6 8 8
Balance at end of period 1,163 1,162 1,160 1,158 1,163 1,160
Treasury Stock            
Increase (Decrease) in Stockholders' Equity            
Balance at beginning of period (1,553) (1,555) (1,393) (1,355) (1,555) (1,355)
Repurchases of common stock, net 0 (14) 0 (55) (14) (55)
Share-based compensation, net of issuance 0 16 2 17 16 19
Balance at end of period (1,553) (1,553) (1,391) (1,393) (1,553) (1,391)
Accumulated Other Comprehensive Loss            
Increase (Decrease) in Stockholders' Equity            
Balance at beginning of period (927) (937) (1,025) (1,086) (937) (1,086)
Other comprehensive income 79 10 72 61 89 133
Balance at end of period (848) (927) (953) (1,025) (848) (953)
Retained Earnings            
Increase (Decrease) in Stockholders' Equity            
Balance at beginning of period 5,700 5,610 5,236 5,092 5,610 5,092
Net income attributable to Ingredion 114 142 196 197 256 393
Dividends declared, common stock (53) (52) (52) (53) (105) (105)
Balance at end of period 5,761 5,700 5,380 5,236 5,761 5,380
Non- Redeemable Non- Controlling Interests            
Increase (Decrease) in Stockholders' Equity            
Balance at beginning of period 22 21 21 19 21 19
Less: Net income attributable to non-controlling interests 2 2 2 2 4 4
Dividends declared, common stock (2)   (2)   (2) (2)
Sale of business         (23)  
Other comprehensive income 1 (1)        
Balance at end of period $ 0 $ 22 $ 21 $ 21 $ 0 $ 21